Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders

• 收藏
• 分享

专利权人:

KAI Pharmaceuticals; Inc.

发明人:

BELL, Gregory,WALTER, Sarah,KARIM, Felix

申请号：

AU2014203629

公开号：

AU2014203629A1

申请日:

2014.07.02

申请国别(地区):

AU

年份:

2014

代理人:

摘要：

#$%^&*AU2014203629A120140724.pdf#####Abstract The present invention provides methods and kits for treating hyperparathyroidism, bone disease and/or hypercalcemic disorders. In particular, methods for lowering serum PTH and serum calcium using polycationic calcium 5 modulator peptides are provided. The calcium modulator peptides can be used to treat subjects having, for example: primary, secondary or tertiary hyperparathyroidism hypercalcemia of malignancy metastatic bone disease or osteoporosis. 5541552_1 (GHMatters) P81006.AU.1

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/